Clinical Trial Update: Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX for colorectal cancer with liver metastases; the study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING